310 results
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.4
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.3
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.2
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
gj4t4manr78o5
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
EX-10.1
6kyxe8jihh47
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
EX-10.1
jl7ley q8
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
EX-10.1
xnmmw6s
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.2
wyts5q7cc7wzkdvd8
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
rieagsts7d249achzl
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.2
r0sxswo dfg
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.4
yf4o51dtwufeo8uz
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.3
ckeylrke4zptlj8 4xl2
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
khdd3j2zbx4y3yv2
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
9hg6towyiowqp5zc
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
EX-10.1
ocm1e9
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
8-K
EX-10.2
w1mx25
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
S-8
EX-10.1
6hxuy1egegd w6o1q
22 Dec 22
Registration of securities for employees
4:19pm
8-K
EX-10.1
zvv8ef oh3
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm